Human Longevity
Developer of a biotechnology platform designed to combine genomic and phenotypic information to accelerate the understanding of human health. The company's platform addresses the age-related decline i...
Valuation
$250M
Market implied
Share Price
N/A
Total Raised
$1.1B
Last Round
N/A